1)Komori K, Ajioka Y, Watanabe H, et al. Proliferation kinetics and apoptosis of serrated adenoma of the colorectum. Pathol Int 53:277-283, 2003
2)Baas IO, Mulder JW, Offerhaus GJ, et al. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172:5-12, 1994
3)味岡洋一,渡辺英伸,西倉健,他.形態計測とp53蛋白,Ki-67免疫染色からみた大腸腺腫と腺癌.病理と臨 16:37-43, 1998
4)Shia J, Tang LH, Vakiani E, et al. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol 33:1639-1645, 2009
5)Jass JR, Walsh MD. Altered mucin expression in the gastrointestinal tract: a review. J Cell Mol Med 5:327-351, 2001
6)Takata M, Yao T, Nishiyama KI, et al. Phenotypic alteration in malignant trasformation of colonic villous tumours: with special reference to a comparison with tubular tumours. Histopathology 43:332-339, 2003
7)Fujita S, Taniguchi H, Yao T, et al. Multi-institutional study of risk factors of liver metastasis from colorectal cancer: correlation with CD10 expression. Int J Colorectal Dis 25:681-686, 2010
8)Hirono H, Ajioka Y, Watanabe H, et al. Bidirectional gastric differentiation in cellular mucin phenotype(foveolar and pyloric)in serrated adenoma and hyperplastic polyp of the colorectum. Pathol Int 54:401-407, 2004
9)八尾隆史.大腸上皮性腫瘍における粘液形質発現の意義.胃と腸 45:705-709, 2010
10)Shiroshita H, Watanabe H, Ajioka Y, et al. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC and CD10 stains. Pathol Int 54:311-321, 2004
11)味岡洋一,渡辺英伸,須田和敬,他.病理学的診断─Dysplasia,癌の生検診断のプロセス.早期大腸癌 9:63-71, 2005